FDA Warns Of Antacid Risks

10 September 1995

Researchers from the US Food and Drug Administration have warned that 14 deaths, 31 hospitalizations and four cases of disability linked to magnesium poisoning from antacid overuse have been reported since 1968.

Man C Fung, lead author of the FDA report, said that in the case of common products such as Maalox and Mylanta, "people drink them like water." Dr Fung and his co-authors said consumers often underestimate the danger and may not recognize the symptoms of magnesium poisoning, which include clumsiness, weakness, paralysis, drowsiness, confusion and coma.

Some types of Mylanta and Maalox do not contain magnesium, and Dr Fung advises consumers to check ingredients. However, Robert Kneffen, a spokesman for Johnson & Johnson Pharmaceuticals (which makes Mylanta), said that the product was safe when used in accordance with the package labelling. A spokesman for Ciba-Geigy, which produces Maalox, declined to comment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight